Polymyxin Detection Antibodies via Selective Amino Group Segmentation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting polymyxins, such as Polymyxin B and Colistin, face challenges in achieving specific binding due to the use of non-targeted approaches that may mask epitopes, leading to inadequate sensitivity and cross-reactivity, especially in the presence of chemically related variants like Colistin A and B, and Polymyxin B1 and B2.

Innovation Solution

A targeted synthetic method is employed to create haptens, immunogens, and tracers with specific structural modifications, allowing for precise derivatization and enhanced binding capabilities, using structures like benzyl or isobutyl groups and spacers that facilitate bonding with antigenicity conferring carrier materials or horseradish peroxidase, resulting in antibodies that can specifically bind Colistin and Polymyxin B with high sensitivity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If a non-targeted approach with all primary amino groups open to derivatisation is used, then the immunogen can be easily synthesized, but the epitopes of the target peptide may be masked by the conjugated carrier proteins, leading to poor antibody binding

Engineering Contradiction:
Improveimmunogen synthesisVSAvoidantibody binding
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The invention segments the polymyxin structure by selectively derivatising only the terminal alpha-amino group while leaving the four side-chain alpha-amino groups unprotected. This segmentation approach ensures that critical epitopic regions (the side-chain amino groups) remain accessible for antibody binding, while still allowing conjugation to carrier proteins through the terminal amino group. The segmented protection strategy resolves the contradiction by maintaining both ease of synthesis and reliable antibody binding.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention applies local quality by differentiating the treatment of different amino groups within the polymyxin molecule. The terminal alpha-amino group is protected for conjugation purposes, while the side-chain alpha-amino groups are kept unprotected to maintain epitope accessibility. This localized differentiation ensures that each region of the molecule serves its appropriate function: the terminal group facilitates immunogen construction while the side chains preserve binding capability.

Inventive Principle:
Principle #3Local quality

2Ease of manufacture

If antibodies are raised using parent Polymyxin B structure with non-targeted derivatisation, then the immunogen can be produced, but the antibodies do not exhibit appreciable binding to both Polymyxin B and Colistin due to masked epitopes

Engineering Contradiction:
Improveimmunogen productionVSAvoiddetection sensitivity
Core Design Contradiction:
Ease of manufactureVSMeasurement precision

Solution Approach 1:

The selective protection strategy segments the amino groups into two functional categories: the terminal alpha-amino group for conjugation and the side-chain alpha-amino groups for epitope formation. This segmentation enables the production of immunogens that maintain critical binding regions while facilitating immunogen construction, thereby achieving both ease of manufacture and high detection sensitivity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention changes the chemical state (protected vs. unprotected) of specific amino groups to optimize both immunogen production and antibody binding. By controlling the protection status of different amino groups, the method achieves precise control over both the ease of immunogen manufacture and the detection sensitivity of the resulting antibodies.

Inventive Principle:
Principle #35Parameter changes

3Ease of manufacture

If all primary amino groups are made open to bonding, then the immunogen synthesis is simplified, but the subsequently raised antibody does not exhibit appreciable binding to target peptides

Engineering Contradiction:
Improveimmunogen synthesisVSAvoidassay performance
Core Design Contradiction:
Ease of manufactureVSEase of operation

Solution Approach 1:

The invention segments the amino group functionality to resolve the contradiction between simplified synthesis and effective assay performance. By protecting only the terminal alpha-amino group while leaving side-chain amino groups unprotected, the method maintains simple immunogen synthesis procedures while ensuring that critical epitopic regions remain accessible for effective antibody binding and assay performance.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The antibodies derived from these immunogens exhibit sufficient sensitivity to detect both Colistin and Polymyxin B, even in the presence of their variants, enabling effective assays and reducing the risk of interference from bacterial lipopolysaccharides, thus addressing the limitations of existing detection methods.

Implementation Method 1

The antibodies derived from these immunogens exhibit sufficient sensitivity to detect both Colistin and Polymyxin B

Methodology Applied
Scientific EffectAntigen-antibody binding:

Implementation Method 2

A targeted synthetic method is employed to create haptens, immunogens, and tracers with specific structural modifications, allowing for precise derivatization and enhanced binding capabilities

Methodology Applied
Scientific EffectAntigen-antibody binding:

Data Source

PatentUS10620225B2Detection of polymyxins
Publication Date: 2020.04.14 NORTHERN BANK LTD
  • US10620225B2 patent drawing
  • US10620225B2 patent drawing
  • US10620225B2 patent drawing

AI summary

The present invention relates to antibodies for use in detecting polymyxins and tracers; and to a single-capture immunodetection method and kits, each utilising the antibodies of the invention, and disclosed tracers.